CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

ABBOTT INDIA LTD.

NSE : ABBOTINDIABSE : 500488ISIN CODE : INE358A01014Industry : Pharmaceuticals & DrugsHouse : Abbott India - MNC
BSE28869.3542.5 (+0.15 %)
PREV CLOSE () 28826.85
OPEN PRICE () 29279.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 223
TODAY'S LOW / HIGH ()28651.75 29279.95
52 WK LOW / HIGH ()25260.2 35921.55
NSE28945.0095 (+0.33 %)
PREV CLOSE() 28850.00
OPEN PRICE () 28850.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 8644
TODAY'S LOW / HIGH() 28660.00 29140.00
52 WK LOW / HIGH ()25325 37000
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1944

Management Info :

Munir Shaikh - Chairman Kartik Rajendran - Managing Director

Registered Office :

Address : Unit No. 3,Corporate Park,Sion Trombay Road,
Mumbai,
Maharashtra-400071

Phone : 022-50461000 / 2000 / 67978888

Website : www.abbott.co.in

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
07Nov Abbott India informs about newspaper p
Pursuant to Regulation 47 of the Securities and Exchange Board of India..
01Aug Abbott India informs about disclosure
In the matter of compounding application filed by the Company with the R..
29Jul Abbott India informs about newspaper
Pursuant to Regulation 30 of the Securities and Exchange Board of India..
26Jun Abbott India informs about closure of
Abbott India has informed that, in accordance with the provisions of the..
19Jun Abbott, MSD Pharmaceuticals enter into
Abbott and MSD Pharmaceuticals have entered into partnership for distrib..
Financials
in Millions
QTR Sep 25 ANNUAL 25
Net Profit4152.714144.4
Gross Profit 5459.3 18869.5
Operating Profit 5721.219701.8
Net Sales 17571.564091.5
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Alkem Laboratories (BSE)
 5689.30 (1.38%)
M.Cap ( in Cr)
68024.12
Glaxosmithkline Phar (BSE)
 2543.10 (1.35%)
M.Cap ( in Cr)
43081.65
Wockhardt (BSE)
 1360.10 (2.16%)
M.Cap ( in Cr)
22100.56
RPG Life Sciences (BSE)
 2228.80 (1.27%)
M.Cap ( in Cr)
3686.22
Everest Organics (BSE)
 437.15 (6.18%)
M.Cap ( in Cr)
424.50
Shareholding Pattern
PROMOTERS 74.99%
NON-INSTITUTION 15.75%
MUTUAL FUNDS/UTI 7.78%
FI/BANKS/INSURANCE 1.07%
GOVERNMENT 0%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX85712.37447.05 (0.52%)
NIFTY26186.45152.70 (0.59%)
Dow Jones 47954.99104.05 (0.22%)
Nasdaq 23578.1372.99 (0.31%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI